Autologous stem cell transplantation (ASCT) versus oral melphalan and high-dose dexamethasone in patients with AL (primary) amyloidosis: Results of the French multicentric randomized trial (MAG and IFM intergroup).

被引：0
|
作者：
Jaccard, A
Moreau, P
Leblond, V
Leleu, X
Benboubker, L
Hermine, O
Recher, C
Malphette, M
Lioure, B
Royer, B
Grosbois, B
Jaubert, J
Preux, PM
Cogne, M
Fermand, JP
机构：
[1] CHU Limoges, Limoges, France
[2] CHU Nantes, F-44035 Nantes 01, France
[3] CHU Lille, F-59037 Lille, France
[4] CHU Tours, Tours, France
[5] CHU Toulouse, Toulouse, France
[6] Pitie & Necker, Paris, France
[7] CHU Strasbourg, F-67000 Strasbourg, France
[8] CHU Amiens, Amiens, France
[9] CHU St Etienne, St Etienne, France
[10] CHU Rennes, Rennes, France
[11] Hop St Louis, Paris, France
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
421
引用
收藏
页码：127A / 127A
页数：1
相关论文
共 50 条
  • [1] Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone In Patients with AL (Primary) Amyloidosis: Long Term Follow-up of the French Multicentric Randomized Trial
    Jaccard, Arnaud
    Leblond, Veronique
    Royer, Bruno
    Leleu, Xavier
    Delarue, Richard
    Kolb, Brigitte
    Deconinck, Eric
    Stamatoullas, Aspasia
    Coppo, Paul
    Arnulf, Bertrand
    Hermine, Olivier
    Moreau, Philippe
    Fermand, Jean Paul
    BLOOD, 2010, 116 (21) : 576 - 577
  • [2] Melphalan and high-dose dexamethasone in patients with AL (primary) amyloidosis ineligible for autologous stem cell transplantation.
    Palladini, G
    Perfetti, V
    Obici, L
    Merlini, G
    BLOOD, 2002, 100 (11) : 397A - 398A
  • [3] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [4] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis
    Knop, S
    Lengerke, C
    Hebart, H
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S165 - S165
  • [5] Oral Cyclic Melphalan and Dexamethasone in the Treatment of Patients with AL Amyloidosis; Ineligible for High-Dose Melphalan and Stem Cell Transplantation.
    Sanchorawala, Vaishali
    Seldin, David C.
    Sloan, John Mark
    Berk, John L.
    Skinner, Martha
    BLOOD, 2009, 114 (22) : 748 - 748
  • [6] Cardiac transplant followed by high-dose melphalan and autologous stem cell transplantation (ASCT) for patients with AL amyloidosis and severe heart failure
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    MacGillivray, Thomas E.
    Chung, Stephen S.
    Dec, G. W.
    Seldin, David C.
    McAfee, Steven L.
    Ballen, Karen
    Attar, Eyal
    Skinner, Martha
    Madsen, Joren C.
    Semigran, Marc J.
    BLOOD, 2007, 110 (11) : 225A - 225A
  • [7] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
  • [8] High-Dose Melphalan and Autologous Hematopoietic Stem Cell Transplantation in Primary Amyloidosis: Single-Center Results
    Charlinski, G.
    Ziarkiewicz, M.
    Boguradzki, P.
    Wiater, E.
    Torosian, T.
    Dwilewicz-Trojaczek, J.
    Wiktor-Jedrzejczak, W.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (08) : 2877 - 2881
  • [9] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    V Sanchorawala
    DG Wright
    DC Seldin
    LM Dember
    K Finn
    RH Falk
    J Berk
    K Quillen
    M Skinner
    Bone Marrow Transplantation, 2001, 28 : 637 - 642
  • [10] Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis
    Sanchorawala, Vaishali
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 9 - 17
12345